Scintigraphic Imaging of Pheochromocytomas by Means of Metaiodobenzylguanidine (MIBG)

  • B. Shapiro
  • J. C. Sisson
  • O. Geatti
  • P. Eyre
  • M. Lynn
  • W. H. Beierwaltes
Conference paper


Pheochromocytomas and functioning paragangliomas (extra-adrenal pheochromocytomas) remain a significant clinical problem [1, 2], and, while unusual, are by no means rare tumors [2, 3], The clinical manifestations are protean [1, 2], but the introduction of sensitive and specific assays for plasma catecholamines, urinary catecholamines, and catecholamine metabolites have made the biochemical diagnosis of pheochromocytoma easier [4–6]. Successful therapy hinges on the accurate location of all tumor deposits to permit their extirpation [1, 2, 7].


MIBG Uptake Scintigraphic Image MIBG Scintigraphy Normal Adrenal Medulla Suspected Pheochromocytoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Freier DT, Eckhauser FE, Harrison TS (1980) Pheochromocytoma: a persistently problematic and still potentially lethal disease. Arch Surg 115:388–391PubMedGoogle Scholar
  2. 2.
    Manger WM, Gifford RW (1982) Hypertension secondary to pheochromocytoma. Bull NY Acad Med 58:139–158Google Scholar
  3. 3.
    St. John Sutton MG, Sheps SG, Lie JT (1981) Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 56:354–360Google Scholar
  4. 4.
    Bravo EL, Tarazi RC, Gifford RW, Stewart BH (1979) Circulating and urinary catecholamines in pheochromocytoma: diagnostic and pathophysiologic implications. New Engl J Med 301:682–686PubMedCrossRefGoogle Scholar
  5. 5.
    Freier DT, Harrison TS (1973) Rigorous biochemical criteria for the diagnosis of pheochromocytoma. J Surg Res 14:177–180PubMedCrossRefGoogle Scholar
  6. 6.
    Bravo EL, Tarazi RC, Fouad FM, Vindt DG, Gifford RW (1981) Clonidine-suppression: a useful aid in the diagnosis of pheochromocytoma. New Engl J Med 305:623–626PubMedCrossRefGoogle Scholar
  7. 7.
    Van Heerden JA, Sheps SG, Hamberger B (1982) Pheochromocytoma: current status and changing trends. Surgery 91:367–373PubMedGoogle Scholar
  8. 8.
    Stewart BH, Bravo EL, Haaga J, Meaney TF, Tarazi R (1978) Localization of pheochromocytoma by computed tomography. New Engl J Med 299:460–461PubMedCrossRefGoogle Scholar
  9. 9.
    Dunnick NR, Doppman JL, Gill JR, Strott CA, Keiser HR, Brennan MF (1982) Localization of functional adrenal tumors by computed tomography and venous sampling. Radiology 142:429–433PubMedGoogle Scholar
  10. 10.
    Adams JE, Johnson RJ, Rickards D, Isherwood I (1983) Computed tomography in adrenal disease. Clin Radiol 34:39–49PubMedCrossRefGoogle Scholar
  11. 11.
    Yeh H-C (1980) Sonography of the adrenal glands, normal glands and small masses. AJR 135:1167–1177PubMedGoogle Scholar
  12. 12.
    Bowerman RA, Silver TM, Jaffe MJ, Stuck KJ, Hinerman DL (1981) Sonography of adrenal pheochromocytomas. AJR 137:1227–1231PubMedGoogle Scholar
  13. 13.
    Jones DH, Allison CA, Hamilton CA, Reid JL (1979) Selective venous sampling in the diagnosis and localization of pheochromocytoma. Clin Endocrinol 10:179–186CrossRefGoogle Scholar
  14. 14.
    Rossi P, Young IS, Panke WF (1968) Techniques, usefulness and hazards of arteriography of pheochromocytoma: review of 99 cases. JAMA 205:547–553PubMedCrossRefGoogle Scholar
  15. 15.
    Kinkhabwala MN, Conradi H (1972) Angiography of extra-adrenal pheochromocytoma. J Urol 108:666–668PubMedGoogle Scholar
  16. 16.
    Sisson JC, Frager MS, Valk TW, Gross MD, Swanson DP, Wieland DM, Tobes MC, Beierwaltes WH, Thompson NW (1981) Scintigraphic localization of pheochromocytoma. New Engl J Med 305:12–17PubMedCrossRefGoogle Scholar
  17. 17.
    Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH (1985) 131-I-met-aiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases (441 studies). J Nucl MedGoogle Scholar
  18. 18.
    Shapiro B, Sisson JC, Kalff V, Glowniak JV, Satterlee WG, Glazer GW, Francis IR, Bowers R, Thompson NW, Orringer M, Gross MD, Beierwaltes NJ (1984) The location of middle mediastinal pheochromocytomas. J Thorac Cardiovasc Surg 87:814–820PubMedGoogle Scholar
  19. 19.
    Shapiro B, Sisson JC, Lloyd R, Nakajo M, Satterlee WG, Beierwaltes WH (1984) Malignant pheochromocytoma: clinical, biochemical and scintigraphic characterization. Clin Endocrinol 20:189–203CrossRefGoogle Scholar
  20. 20.
    Kalff V, Sisson JC, Beierwaltes WH (1982) Adrenal gland identification: pre-operative assessment Surgery 91:374–376PubMedGoogle Scholar
  21. 21.
    Valk TW, Frager MS, Gross MD, Sisson JC, Wieland DM, Swanson DP, Mangner TJ, Beierwaltes WH (1981) Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-meta-iodobenzylguanidine. Ann Intern Med 94:762PubMedGoogle Scholar
  22. 22.
    Kalff V, Shapiro B, Lloyd R, Sisson JC, Holland K, Nakajo M, Beierwaltes WH (1982) The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis. Arch Intern Med 142:2092–2098PubMedCrossRefGoogle Scholar
  23. 23.
    Glowniak JV, Shapiro B, Sisson JC, Thompson NW, Coran AG, Lloyd RV, Kelsch RC, Beierwaltes WH (1985) Familial extra-adrenal pheochromocytoma: a new syndrome. Arch Intern Med 145:257–261PubMedCrossRefGoogle Scholar
  24. 24.
    Lynn MD, Shapiro B, Sisson JC, Swanson DP, Mangner TJ, Wieland DM, Meyers LJ, Beierwaltes WH (1984) Portrayal of pheochromocytoma and normal human adrenal medulla by 123-I-meta-iodobenzylguanidine (123-I-MIBG). J Nucl Med 25:436–440PubMedGoogle Scholar
  25. 25.
    Treuner J, Feine U, Niethammer D, Muller-Schaumburg W, Meinke J, Eibach E, Dopfer R, Klingebiel TH, Grumbach ST (1984) Scintigraphic imaging of neuroblastoma with 131I-MIBG. Lancet 1:333–334PubMedCrossRefGoogle Scholar
  26. 26.
    Fischer M, Kamanabroo D, Sanderkamp H, Proske T (1984) Scintigraphic imaging of carcinoid tumors with 131I-MIBG. Lancet 2:165 (letter)PubMedCrossRefGoogle Scholar
  27. 27.
    Endo K, Shiomi K, Kasagi K, Konishi J, Torizuka K, Nakao K, Tanimura H (1984) Imaging of medullary carcinoma of the thyroid with 131I-MIBG. Lancet ii:233CrossRefGoogle Scholar
  28. 28.
    Smit AJ, Van Essen LH, Hollema H, Muskiet FAJ, Piers OA (1984) 131I-MIBG uptake in a non-secreting paraganglioma. J Nucl Med 25:984–986PubMedGoogle Scholar
  29. 29.
    Peuler JD, Johnson GA (1971) Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 21:625–636CrossRefGoogle Scholar
  30. 30.
    Von Euler US, Lishajko F (1959) The estimation of catecholamines in urine. Acta Physiol Scand 45:122–132CrossRefGoogle Scholar
  31. 31.
    Wieland DM, Wu J-I, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH (1980) Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med 21:349–353PubMedGoogle Scholar
  32. 32.
    McEwan AJ, Shapiro B, Sisson JC, Beierwaltes WH, Ackery DM (1985) Radi- oiodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors. Semin Nucl Med 15:132–153PubMedCrossRefGoogle Scholar
  33. 33.
    Lynn MD, Shapiro B, Sisson JC, Beierwaltes WH, Meyers LJ, Ackerman R, Mangner TJ (1985) Improved visualization of pheochromocytomas and normal adrenal medullae with 123I-MIBG scintigraphy. Radiology (in press)Google Scholar
  34. 34.
    Sisson JC, Shapiro B, Beierwaltes WH (1984) Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med 25:198–206Google Scholar
  35. 35.
    Sisson JC, Shapiro B, Glowniak JV, Beierwaltes WH, Mangner TJ, Wieland DM, Carey JC, Petry NA, Copp JE, Eyre PL (1984) 131I-MIBG treatment of malignant pheochromocytoma. J Nucl Med 25:p 72Google Scholar
  36. 36.
    Anonymous (1983) Clinical value of adrenomedullary scintigraphy with 131I-MIBG. Nucl Compact 14:318 (Editorial)Google Scholar
  37. 37.
    Brown ML, Sheps SG, Sizemore G (1984) MIBG in the evaluation of suspected pheochromocytoma: Mayo Clinic experience. J Nucl Med 25:p 94 (Abstract)Google Scholar
  38. 38.
    Baulieu JL, Guilloteau C, Canbom C, Viel C, Baulieu F, Itti R, Pourcelot L, Besnard JC (1984) MIBG scintigraphy: A one-year experience. J Nucl Med 25:p 111 (Abstract)Google Scholar
  39. 39.
    Ackery DM, Tippett P, Condon D et al. (1984) New approach to the localization of phaeo- chromocytoma: Imaging with 131I-MIBG. Br Med J 288:1587–1591CrossRefGoogle Scholar
  40. 40.
    Francis IR, Glazer GM, Shapiro B et al. (1983) Complementary roles of CT scanning and 131-I-MIBG scintigraphy in the diagnosis of pheochromocytoma. Am J Roentgenol 141:719–725Google Scholar
  41. 41.
    Shapiro B, Copp JE, Eyre P et al. (1984) A new and efficient approach to the diagnosis and location of pheochromocytomas. Clin Res 32:300A (Abstract)Google Scholar
  42. 42.
    Horne T, Hawkins LA, Britton KE, Granowska M, Bouloux P, Besser GM (1984) Imaging of pheochromocytoma and adrenal medulla with 123-I-meta-iodobenzylguanidine. Nucl Med Commun 5:763–768PubMedCrossRefGoogle Scholar
  43. 43.
    Hawkins LA, Britton KE, Shapiro B (1980) Selenium 75 seleno-methyl-cholesterol: a new agent for quantitative functional scintigraphy of the adrenals: physical aspects. Br J Radiol 53:883–889PubMedCrossRefGoogle Scholar
  44. 44.
    Munkner T (1985) 131I-metaiodobenzylguanidine scintigraphy of neuroblastomas. Semin Nucl Med 15:154–160PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • B. Shapiro
    • 1
  • J. C. Sisson
  • O. Geatti
  • P. Eyre
  • M. Lynn
  • W. H. Beierwaltes
  1. 1.Division of Nuclear Medicine, Department of Internal MedicineUniversity of MichiganAnn ArborUSA

Personalised recommendations